KAY CHRISTINA 4
4 · INTEGRATED BIOPHARMA INC · Filed Nov 10, 2022
Insider Transaction Report
Form 4
KAY CHRISTINA
DirectorExecutive Vice President
Transactions
- Award
Stock Option (right to buy)
2022-11-09+100,000→ 100,000 totalExp: 2032-11-09→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock on the fifth trading day after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2022, with the Securities and Exchange Commission.
- [F2]The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 9, 2023.